Clinical CYP2D6 Genotyping to Personalize Adjuvant Tamoxifen Treatment in ER-Positive Breast Cancer Patients: Current Status of a Controversy
Article in Cancers (February 2021)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Adjuvant Therapy for Breast Cancer: Hormonal Therapy
Book chapter (September 2014)
Determination of CYP2D6 *3, *4, and *10 frequency in women with breast cancer in São Luís, Brazil, and its association with prognostic factors and disease-free survival
Article in Brazilian Journal of Medical and Biological Research (September 2014)